In summary, we develop an open-source software package, termed receptLoss, to identify novel subgroups of endometrial cancer patients based on patterns of nuclear hormone receptor expression between tumor and adjacent normal tissue. This evidence concerns the gene NR0B1 and endometrial cancer.